Reimagining the Future of Cardiovascular Health
When Dr. Denton Cooley and his colleagues founded the Texas Heart Institute (THI), it was with the firm belief that excellence in...
Office of Research Administration
Dr. James Martin – Director of the Cardiomyocyte Renewal Lab at Texas Heart Institute – Elected to the 2021 Class of the National Academy of Inventors
Houston, TX (February 11, 2021) – The Texas Heart Institute is pleased to announce that Dr. James Martin, Director of its...
Cell adhesion research could lead to a new pain alternative for patients with inflammatory conditions
Today more than 30 million patients suffer from painful inflammatory conditions. Prescription opioid pain relievers are commonly prescribed for these...
In Memoriam James T. Willerson, MD
It is with great sadness that we inform you of the passing of THI’s President Emeritus, Dr. James T....
New Clinical Trial at the Texas Heart Institute Explores Heart Failure Treatment After Heart Attack
Houston, TX – August 24, 2020– Heart disease is the leading cause of death in both women and men in...
Technology Co-Invented by THI Scientists In the News
Technology co-invented by scientists at the Texas Heart Institute and 7 Hills Pharma received broad patent protection from the U.S....
Harnessing hydrogels to fine-tune the body’s inflammatory response
Rice University partnered with the Texas Heart Institute (THI) to define the body’s response to their injectable hydrogels that are...
Texas Heart Institute’s molecular discovery at the heart of a new vaccine development program
A promising molecular technology co-invented by scientists at the Texas Heart Institute and 7 Hills could soon enhance the effectiveness...
Texas Heart Institute Discovery to Enhance the Immune System Moves Closer to Clinical Testing
A promising technology invented at the Texas Heart Institute is one step closer to being tested in a clinical study...
